0001214659-20-002746.txt : 20200318 0001214659-20-002746.hdr.sgml : 20200318 20200318164520 ACCESSION NUMBER: 0001214659-20-002746 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200316 FILED AS OF DATE: 20200318 DATE AS OF CHANGE: 20200318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boyd Peter E. CENTRAL INDEX KEY: 0001739816 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38599 FILM NUMBER: 20725142 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc. CENTRAL INDEX KEY: 0001398733 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208623253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-941-1900 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: MonoSol Rx, Inc. DATE OF NAME CHANGE: 20070507 4 1 marketforms-48349.xml PRIMARY DOCUMENT X0306 4 2020-03-16 0001398733 Aquestive Therapeutics, Inc. AQST 0001739816 Boyd Peter E. C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059 false true false false SVP-Bus. Process & Info. Tech. Common Stock 2020-03-16 4 P false 2000 1.50 A 52239 D Non-Qualified Stock Option (right to buy) 1.54 2020-03-16 4 A false 50700 0 A 2030-03-16 Common Stock 50700 50700 D The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries. /s/ Robert Arnold, as Attorney-In-Fact 2020-03-18